Angelman Syndrome clinical trials at UCSF

1 in progress, 0 open to eligible people

GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)
Sorry, in progress, not accepting new patients
The primary objective of this study is to evaluate the effect of GTX-102 in cognitive function in participants with deletion-type Angelman Syndrome (AS).
San Francisco 5391959, California 5332921 and other locations

Last updated: July 31, 2025